Price
CHART BY
Frequently asked questions
What is Evotec's market capitalization?
What is the Earnings Per Share (EPS) for Evotec?
What are the analyst ratings and target price for Evotec's stock?
What is Evotec's revenue over the trailing twelve months?
What is the free cash flow of Evotec?
How many employees does Evotec have, and what sector and industry does it belong to?
What is the free float of Evotec's shares?
Financials
- Market Cap
- $1.28B
- EPS (TTM)
- -$1.059
- Free Float
- 148.14M
- Revenue (TTM)
- $894.34M
- Free Cashflow (TTM)
- -$83.37M
Pricing
- 1D span
- $7.111$7.272
- 52W span
- $5.519$9.738
Analyst Ratings
The price target is $10.41 and the stock is covered by 10 analysts.
Buy
7
Hold
3
Sell
0
Information
Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.
- Employees
- 4,827
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- DE0005664809
- Primary Ticker
- EVT